Dr. Laura B. Dickson's lab focuses on understanding how the adaptation of the Aedes aegypti mosquito to low humidity affects its ability to spread diseases like Zika and dengue. By investigating the physiological and genetic changes that occur in these mosquitoes under dry conditions, the lab aims to uncover new ways to develop effective control measures against vector-borne diseases. Their research combines field studies with molecular biology techniques to explore the relationship between environmental factors and virus transmission.

Dr. Nisha Jain Garg's lab focuses on understanding the molecular mechanisms behind Chagas disease, particularly how certain proteins affect heart function during the disease. By studying how the splicing of specific genes changes during infection, the lab aims to find new therapeutic strategies that could improve heart health in patients affected by Chagas. Their work bridges molecular biology and cardiology, aiming to offer insights into potential treatments for this serious condition.

Dr. Gene Garrard Olinger's lab at the University of Texas Medical Branch focuses on maintaining and optimizing the Galveston National Laboratory, a high-containment facility dedicated to studying infectious diseases. The lab provides unique resources for researchers to develop therapeutics, diagnostics, and vaccines for dangerous pathogens, while also training the next generation of experts in global health. Through rapid response capabilities, the lab plays a critical role in addressing public health emergencies and bioterrorism threats.

Professor Shinji Makino leads a research lab at the University of Texas Med Br Galveston focused on understanding the Rift Valley fever virus, which can cause serious diseases like hemorrhagic fever in humans and livestock. The lab investigates how the virus's RNA is packaged, which is crucial for developing antiviral drugs and vaccines. Their work aims to prevent outbreaks by elucidating the viral mechanisms that could aid in public health strategies against this and similar viruses.

Dr. Haitao Hu's lab at the University of Texas Medical Branch focuses on researching new strategies to fight HIV by targeting specific cellular proteins that regulate the virus's ability to remain dormant in the body. Their work involves using small molecules to modulate these proteins and enforce HIV latency, which could lead to innovative treatments for HIV infections. The lab employs a mix of molecular and cell biology techniques to explore these interactions and develop potential therapeutic solutions.

Dr. Janice J. Endsley's lab at the University of Texas Medical Branch in Galveston focuses on understanding how certain immune cells called macrophages respond to lung infections, particularly those caused by Mycobacterium tuberculosis (the bacterium that causes tuberculosis). By studying the role of specific proteins in these cells, the lab investigates how infections and conditions like HIV can affect the immune response and inflammation. The goal is to find new ways to enhance immune function and improve treatment strategies for tuberculosis and related infections.

Dr. Ashok K Chopra's lab focuses on developing innovative vaccines against the plague by studying the immunological responses in both mice and non-human primates. By identifying new virulence genes of the plague bacteria, Yersinia pestis, the lab aims to create safer and more effective vaccines than those currently available. The research not only enhances our understanding of how to combat this deadly disease but also seeks to address public health risks posed by antibiotic-resistant strains.

Dr. Tian Wang's lab focuses on developing innovative vaccines to combat COVID-19, particularly using a novel approach involving porous silicon microparticles. They aim to enhance both systemic and mucosal immunity against SARS-CoV-2 variants, making vaccination more effective through different delivery methods. The research holds potential for long-term protection against viral infections and improving public health responses to pandemics.